Darbà, JosepKaskens, LisettePérez Álvarez, NúriaPalacios Ruiz, Lucas SantiagoNeyro, José LuisRejas, Javier2016-12-012016-12-012015-041471-2458https://hdl.handle.net/2445/104345To estimate the disability-adjusted life years (DALY) in a nationwide representative sample of postmenopausal women with osteoporosis. The effects of drug-based therapy and risk factors for osteoporotic bone fractures on DALY losses were also explored. DALY were estimated based on participant's clinical characteristics and Health-Related Quality-of-Life (HRQoL) data obtained from a cross-sectional, epidemiological one-visit study (the GINERISK study). The study enrolled postmenopausal women (at least 12-months after their last menstrual period) with osteoporosis, above 18-years old, who attended Spanish outpatient Gynaecology clinics. HRQoL was assessed using the generic SF-12v2 questionnaire, which was used to derive disutility values. Mortality rates were extracted from the Spanish national statistics database. Factors explored to be associated with DALY losses were examined using ANOVA, ANCOVA and MANCOVA models.12 p.application/pdfengcc-by (c) Darbà, Josep et al., 2015http://creativecommons.org/licenses/by/3.0/esMenopausaOsteoporosiAnàlisi cost-beneficiMenopauseOsteoporosisCost effectivenessDisability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness studyinfo:eu-repo/semantics/article6582212016-12-01info:eu-repo/semantics/openAccess25880810